All
Catalent to Acquire RheinCell Therapeutics
Catalent expands capabilities for stem cell-based therapies with acquisition of RheinCell’s GMP-grade human iPSCs.
Vectura Partners with Cannabinoid Medicines Company
Vectura will provide preclinical development services for Incannex’s inhaled drug product for the treatment of traumatic brain injury.
AstraZeneca Doses Patients in COVID-19 Variant Vaccine in Trial
The first participants, both previously vaccinated and unvaccinated, receive AstraZeneca’s new COVID-19 variant vaccine AZD2816.
WuXi STA to Build New Manufacturing Campus
WuXi STA’s Delaware campus will contain clinical and commercial manufacturing capabilities for small molecules and novel molecular modalities.
Celularity and Arthrex Announce Distribution Agreement
Arthrex to receive exclusive rights to distribute and commercialize Celularity’s placental-derived biomaterial products for orthopedics and sport medicine in the United States.
The Necessity of Prioritizing Cleaning Validation
With COVID-19 vaccine facilities receiving recent citations, it is evident that failure to meet cleaning and sanitization requirements puts patients, facilities, and operators at risk.
Corbus Pharmaceuticals Expands Pipeline with Two New mAbs
Corbus Pharmaceuticals has licensed two integrin-targeting mAbs, expanding its therapeutics pipeline into inflammatory, fibrotic, and metabolic diseases as well as cancer.
Chalmers Researchers Develop Fluorescence Method to Track RNA
Chalmers University researchers have developed a method to label and track mRNA molecules.
Amgen Builds Packaging Facility in Ohio
Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024.
Yposkesi’s Bioproduction Project Selected for French Government Investment
CDMO Yposkesi will increase its current gene therapy vector capacity through French government’s “Plan de Relance” scheme.
Thermo Fisher Scientific’s Clinic Solution Aims to Accelerate Biologic Drug Development
Thermo Fisher Scientific has introduced its new Quick to Clinic solution, which is designed to accelerate biologic drug development from discovery to the IND phase in a shortened period.
CatSci’s New UK Laboratory Now Open and Poised to be Analytical Center of Excellence
CatSci has opened its new Dagenham, UK-based laboratory, which is dedicated to analytical excellence.
CGT Catapult Announces Expansion into Scotland
The Cell and Gene Therapy Catapult will establish offices and laboratories in Edinburgh, Scotland.
Evonik Offers Green Tech for Sustainable Pharmaceutical Production
Evonik has released an innovative green technology that can enable the large-scale synthesis of APIs in water.
Pharmapack Innovation Index Reveals Continuing Innovation in Drug Delivery Across Europe
Pharmapack Europe event organizers have revealed increased levels of innovation in drug delivery across the industry, substantiated by the level of regulatory approvals.
Sphere Fluidics and ClexBio Introduce CYTRIX Microfluidic Hydrogel Kit
The CYTRIX Microfluidic Hydrogel Kit is the first in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio.
Miele Earns ACT Label Certification for Three Glassware Washers
The three Miele washer machines have been officially certified with the “eco-nutrition” label by My Green Lab.
Waters’ New SELECT SERIES MRT Mass Spec Platform Delivers Speedy High-Quality Resolution
The new multi reflecting time-of-flight mass spectrometry platform from Waters delivers highest quality resolution at fast speeds.
The Council of Europe Appoints Petra Dörr as Future EDQM Director
The Council of Europe has appointed Petra Dörr, PhD, as the future director of the European Directorate for the Quality of Medicines and Healthcare (EDQM).
Genezen Invests in New CGMP Lentiviral Vector Production Facility
Genezen Laboratories has broken ground on a new current good manufacturing practice (CGMP)-compliant lentiviral vector production facility.
CHMP Recommends EU Approval of Bimekizumab for Plaque Psoriasis
EMA's CHMP has adopted a positive opinion recommending the approval of UCB’s bimekizumab (Bimzelx) for the treatment of plaque psoriasis.
Otsuka Pharmaceuticals Europe Files MAA with EMA for Voclosporin
Otsuka Pharmaceuticals Europe has filed an initial marketing authorization application to the European Medicines Agency for voclosporin.
FDA Adds Warning to mRNA Vaccine Fact Sheets
Reports of myocarditis and pericarditis following Pfizer-BioNTech and Moderna vaccinations prompts warnings.
Tackling Counterfeit Medicines
Pharmaceutical Technology discussed the potential increased risk of counterfeit medicines in the UK post-Brexit and how blockchain could be a useful tool to tackle the issue.
AbbVie to Acquire TeneoOne and Lead Asset for Multiple Myeloma Treatment
AbbVie has exercised its right to acquire TeneoOne, along with its lead immunotherapeutic asset for the potential treatment of multiple myeloma.
Amgen’s Aimovig Approved in Japan for Treating Migraine
Amgen’s Aimovig has become the first and only approved treatment in Japan for treating migraine attacks in adults by blocking the CGRP-R.
Lilly's Investigational Alzheimer's Therapeutic Gets Breakthrough Therapy Designation
FDA has granted breakthrough therapy designation to donanemab, Eli Lilly and Co.’s investigational antibody treatment for Alzheimer’s disease.
Lonza and CellPoint Collaborate to Develop T-cell Based Therapies
The companies will utilize the Cocoon Platform for clinical point-of-care manufacturing.
SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
University of Birmingham Joins Advanced Therapies Skills Training Network
The University of Birmingham has been confirmed as the third National Training Centre in the Advanced Therapies Skills Training Network (ATSTN) initiative
